Search Results

Filter
  • 1-10 of  58 results for ""Hepatitis D, Chronic""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide.

  • Authors : Buti M; Liver Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBER-EHD) del Instituto Carlos III, Barcelona, Spain. Electronic address: .

Subjects: Patient Reported Outcome Measures* ; Quality of Life* ; Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/drug therapy

  • Source: Journal of hepatology [J Hepatol] 2025 Jan; Vol. 82 (1), pp. 28-36. Date of Electronic Publication: 2024 Jul 14.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.

  • Authors : Wedemeyer H; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany. Electronic address: .; Aleman S

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage

  • Source: Journal of hepatology [J Hepatol] 2024 Oct; Vol. 81 (4), pp. 621-629. Date of Electronic Publication: 2024 May 09.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort.

Subjects: Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/epidemiology ; Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/immunology ; Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/genetics

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep; Vol. 146, pp. 107115. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.

  • Authors : Allweiss L; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hannover, Heidelberg and Hamburg-Lübeck-Borstel-Riems Partner Sites, Germany.

Subjects: Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/drug effects ; Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/genetics ; Hepatocytes*/Hepatocytes*/Hepatocytes*/virology

  • Source: Journal of hepatology [J Hepatol] 2024 Jun; Vol. 80 (6), pp. 882-891. Date of Electronic Publication: 2024 Feb 08.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

JAK1 promotes HDV replication and is a potential target for antiviral therapy.

  • Authors : Heuschkel MJ; Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, Strasbourg, France.; Bach C

Subjects: Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/physiology ; Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/drug therapy; Humans

  • Source: Journal of hepatology [J Hepatol] 2024 Feb; Vol. 80 (2), pp. 220-231. Date of Electronic Publication: 2023 Nov 02.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide.

  • Authors : Toniutto P; Hepatology and Liver Transplantation Unit, University of Udine, Italy. Electronic address: .; Falleti E

Subjects: Symporters*/Symporters*/Symporters*/genetics ; Organic Anion Transporters, Sodium-Dependent*/Organic Anion Transporters, Sodium-Dependent*/Organic Anion Transporters, Sodium-Dependent*/genetics ; Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/genetics

  • Source: Journal of hepatology [J Hepatol] 2024 Nov; Vol. 81 (5), pp. 819-826. Date of Electronic Publication: 2024 Jun 18.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies.

  • Authors : Patmore LA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: .; van der Eijk AA

Subjects: Virus Replication*/Virus Replication*/Virus Replication*/drug effects ; Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/drug effects ; Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/physiology

  • Source: Journal of hepatology [J Hepatol] 2024 Jul; Vol. 81 (1), pp. e49-e50. Date of Electronic Publication: 2023 Nov 29.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication.

  • Authors : Gillich N; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Subjects: Hepatitis D, Chronic* ; Interferon-Induced Helicase, IFIH1*/Interferon-Induced Helicase, IFIH1*/Interferon-Induced Helicase, IFIH1*/genetics ; Interferon-Induced Helicase, IFIH1*/Interferon-Induced Helicase, IFIH1*/Interferon-Induced Helicase, IFIH1*/metabolism

  • Source: Journal of hepatology [J Hepatol] 2023 Jan; Vol. 78 (1), pp. 78-89. Date of Electronic Publication: 2022 Sep 22.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The hepatitis delta virus and chronic hepatitis D.

  • Authors : Dandri M; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems partner site, Germany. Electronic address: .

Subjects: Hepatitis D*/Hepatitis D*/Hepatitis D*/epidemiology ; Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/complications; Hepatitis Antibodies

  • Source: Journal of hepatology [J Hepatol] 2022 Nov; Vol. 77 (5), pp. 1448-1450. Date of Electronic Publication: 2022 Jul 15.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  58 results for ""Hepatitis D, Chronic""